Study of the Interactive Effect between Gentamicin and Sulfa-Trimethoprim for Use in the Therapy and Prevention of Disease in Veterinary Medicine
Downloads
The pharmacological interaction of the combination of Gentamicin sulphate and sulfamethoxazole-Trimethoprim was studied. An in vitro challenge method was used for this purpose. The results were used to calculate their interaction using the graphical representation known as ISOBOLOGRAM. The pure salts of Gentamicin sulphate and Sulfamethoxazole-Trimethoprim were used and were obtained from the manufacturer DIPROFA'Q Productos Farmaceuticos Veterinarios, Mexico. The agar bioassay method was used. The following criteria were used to quantify the results: A synergistic effect was defined when the actual/theoretical effect (SMEF) was greater than 1. The additive effect was defined when the SMEF was equal to 1. The area between the antagonism and additive effect was defined as the zone of indifference. When studying the interaction between Gentamicin and Sulfamethoxazole-Trimetroprim it was observed that the best SMF of this antibiotic combination was 2 : 3,. This result allows postulating that the use of this combination of Gentamicin and Sulfamethoxazole-Trimethoprim establishes a well recognised and documented synergistic effect between them and can be recommended in Canids and Felids for the treatment of enteric infections by gram + and gram- germs and other infectious agents sensitive to this combination.
Acar J F. 2000. Antibiotic Synergy and Antagonism. Medical Clinics of North America
, 6, 1 P 1391-1406
Bennet, J. V., Brodie J. L.; Benner, E. J.,Kirby, W. M.M. 1966 Simplified, accurate method for antibiotic assay of clinical specimens. App. Microbiol. 14: 170 -177
Bush, K. (2017). Synergistic Antibiotic Combinations. In: Fisher, J.F., Mobashery, S., Miller, M.J. (eds) Antibacterials. Topics in Medicinal Chemistry, vol 25. Springer, Cham. https://doi.org/10.1007/7355_2017_23
Craig, G.R. 1972. The place for potentiate trimethoprim in the therapy of diseases of the skin in dogs and cats.. J. Small Animal Practice 13: 65 – 70
Craig,G.R. and White G. 1976. Studies in dogs and cats dose with trimethoprim and sulfadiazine. Vet. Rec. 98 (5): 82 – 86
Desbiolles N, Piroth L,, Lequeu C, Neuwirth C, Portier H, and Chavanet P. 2001. Fractional Maximal Effect Method for In Vitro Synergy between Amoxicillin and Ceftriaxone and between Vancomycin and Ceftriaxone against Enterococcus faecalis and Penicillin-Resistant Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 45, 12. p. 3328-3333
Fuentes Hernandez V O. 2000. Farmacología Veterinaria., ISBN 970-27-0165-1 Comisión Editorial de la Universidad de Guadalajara México p 60 – 150
Hamilton-Miller, J. M. T. 1985. Rationalization of terminology and methodology in the study of antibiotic interaction. J. Antimicrob. Chemother. 15:655-658
King, T. C., D. Schlessinger, and D. J. Krogstad. 1981. The assesment of antimicrobial combinations. Rev. Infect. Dis. 3:627-633
Minato, Y., Dawadi, S., Kordus, S.L. et al. Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole. Nat Commun 9, 1003 (2018). https://doi.org/10.1038/s41467-018-03447-
National Committee for Clinical Laboratory Standards. 1994. Performance for antimicrobial susceptibility testing. Standard M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
Norbert Desbiolles, Lionel Piroth, Catherine Lequeu, Catherine Neuwirth, Henri Portier, and Pascal Chavanet. 2001. Fractional Maximal Effect Method for In Vitro Synergy between Amoxicillin and Ceftriaxone and between Vancomycin and Ceftriaxone against Enterococcus faecalis and Penicillin-Resistant Streptococcus pneumoniae.Antimicrobial Agents and Chemotherapy, December 2001, p. 3328-3333, Vol. 45, No. 12
Rahal, J. J. 1978. Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine 57:179-195
Sangaré A K, Rolain J M , Gaudar Weber P and Raoult D. 2016 International Journal of Antimicrobial Agents, 47, 3, P 217-223, Copyright © 2016 Elsevier B.V. and the International Society of Chemotherapy
All Content should be original and unpublished.
